Skip to search.
 TSX Down 0.09% TSX Ventures Down 0.48%

Novartis AG (NVS)

-NYSE
103.85 Down 0.94(0.90%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:104.79
Open:103.95
Bid:103.88 x 1700
Ask:109.17 x 100
1y Target Est:110.13
Beta:0.69
Next Earnings Date:N/A
Day's Range:103.81 - 104.56
52wk Range:84.17 - 105.82
Volume:617,104
Avg Vol (3m):1,314,160
Market Cap:251.35B
P/E (ttm):12.61
EPS (ttm):8.24
Div & Yield:2.67 (2.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVSDown 0.90%251.35B
MRKDown 1.20%167.76B
PFEDown 0.23%211.08B
SNYDown 1.01%132.66B

Key Statistics

Forward P/E (1 yr):18.92
P/S (ttm):4.81
Ex-Dividend Date:02-Mar-15

Analysts

Annual EPS Est (Dec-15) :5.17
Quarterly EPS Est (Jun-15) :1.21
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):2.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback